Airbus SE

TickerAIR.XETRA
Current Price
Airbus SE – stock chart

5-year stock timeline

Airbus Group (AIR.XETRA) — 5‑year timeline (2020–2026). Latest price (2026‑07‑07): 203.9

| Major company- and stock-specific events that likely moved the price (earnings surprises, guidance changes, product/strategy shifts, M&A, regulatory events, management changes, major macro shocks, etc.) | How public and investor perception and narrative around the stock evolved over this period (e.g. "hype growth story", "turnaround", "value trap", "defensive compounder") | Key technical phases on the chart over roughly the last 5 years: big uptrends/downtrends, sideways ranges, breakouts/breakdowns, retests of important levels, and unusually large drawdowns or rallies | |---|---|---| | 31‑Jan‑2020 — Record global bribery/corruption settlement: Airbus agreed coordinated resolutions with French PNF, UK SFO and US DOJ/DoS (~€3.6bn provision), booked as a large one‑off and subject to monitoring/conditions [47][43]. | Immediate investor concern about corporate governance, big one‑off earnings impact and legal overhang; stock carried a governance risk premium into 2020. [47][43] | Pre‑COVID trade was near an all‑time high in Jan‑2020 (~€139); the settlement added downside vulnerability ahead of the pandemic shock. [1] | | Mar–Apr‑2020 — COVID crisis: factory suspensions (France/Spain), delivery deferrals, guidance withdrawn, dividend suspended; liquidity measures (new €15bn credit facility; €2.5bn bond) and production‑rate cuts for A320/A330/A350 families as demand collapsed. Q1 2020 reported sharp profit decline and heavy cash burn. [2][7][11][4] | Stock narrative shifted to "survival / liquidity" and extreme cyclicality; investors focused on cash preservation, delivery cadence and balance‑sheet actions. [7][11][4] | Massive drawdown: share plunge to €49.07 on 18‑Mar‑2020 (~65% from Jan peak); extreme volatility and the single largest structural decline in the window. [1] | | Jun‑2020 → 2021 — Stabilisation & managed ramp: Airbus adapted production/delivery plans (delivered 566 commercial aircraft in 2020 while cutting capex and conserving cash), gradually restarted deliveries and worked supplier network. [1][11] | Perception shifted toward "value / early recovery" as travel demand signalled gradual return; investors tracked delivery ramp & cashflow improvement. [6][1] | Partial V‑recovery from the March low into mid‑2020 (~€84 on 9‑Jun‑2020) followed by extended consolidation through 2020–2021 as recovery visibility remained uncertain. [6][1] | | Nov‑2021 → 2022 — A350 surface/paint & quality issues escalate: operators reported surface degradation; regulators and carriers scrutinised A350 condition; Qatar grounded/blocked some A350s and cancelled further deliveries — dispute escalated publicly and threatened delivery/orders overhang. [23][18][19][15] | Narrative shifted to "quality/operational risk" with fresh downside risk: investors worried about compensation, delivery interruptions and reputational damage. [23][15] | Stock underperformed / traded sideways to weaker through late‑2021 into 2022 while the dispute remained unresolved — a new negative catalyst overlaying the recovery case. [23][15] | | 01‑Feb‑2023 — Airbus & Qatar settle A350 dispute: parties announce amicable settlement, repair programme and reinstatement of previously cancelled A350/A321neo orders (details confidential); legal overhang removed. [28][35][34] | Immediate improvement in sentiment: removal of a major legal/delivery overhang was widely read as a de‑risking catalyst for deliveries and order backlog monetisation. [28][35] | Relief rally / positive momentum shift in early 2023 — market re‑rated execution and delivery visibility into the recovery thesis. [3][34] | | 2022–2023 (supply‑chain era) — Managed production ramp and delivery targets: Airbus moderated narrowbody acceleration due to supplier constraints and re‑established a 720 deliveries target for 2023 while acknowledging lost time in recovery; core profitability for the prior year improved (management commentary). [3] | Narrative shifted from "turnaround" to "managed ramp / execution": investors concentrated on backlog conversion vs supplier execution risk. [3] | Gradual uptrend through 2022–2023 punctuated by news‑driven pullbacks tied to supply‑chain updates; execution beats provoked further rallies. [3][39] | | Full‑year 2023 (reported 14‑Feb‑2024) — Demand rebound: gross commercial aircraft orders 2,319 and net orders 2,094; 735 deliveries in 2023; order backlog ~8,598 aircraft — clear evidence of demand & backlog strength. [39][33] | Re‑rating to a demand‑led recovery story; market narrative matured to "recovery compounder" / delivery‑driven revenue growth rather than residual pandemic risk. [39] | Multi‑quarter breakout and sustained uptrend through 2023 as orders/deliveries materially beat pandemic‑era expectations; reduced structural downside. [39] | | Jul–Nov‑2024 — A321XLR programme milestones: EASA Type Certificate for CFM‑powered A321XLR issued 19‑Jul‑2024; FAA certification followed (early Oct‑2024); first customer deliveries (Iberia) and entry‑into‑service Oct/Nov‑2024 — major product catalyst for long‑range single‑aisle market. [60][70][66][59] | Product‑catalyst narrative strengthened: A321XLR validated Airbus' competitive edge in long‑range single‑aisle and supported medium‑term revenue/delivery profile. [60][66] | Event‑driven breakouts and renewed technical acceleration around certification and delivery announcements; positive technical confirmation of the recovery trend. [60][66] | | Sep‑2024 — A350‑1000 engine incident & regulatory checks: a Cathay Pacific A350‑1000 engine fire prompted EASA precautionary inspections/ADs focused on A350‑1000 components (visual checks/measurements) and short‑term operational checks. [24][27] | Short‑term safety / regulatory overhang for the A350‑1000 sub‑type; investors temporarily cautious pending investigation outcomes and corrective actions. [24][27] | Short‑term volatility and retest of support levels (news‑driven), but limited structural damage where inspections were procedural/light; reflation resumed once issues were contained. [24][27] | | 21‑Feb‑2025 → mid‑2026 — Programme maturation & continued ramp: Pratt & Whitney‑powered A321XLR type certification completed (Feb‑21‑2025), enabling full‑engine‑choice deliveries; Airbus continued ramp planning toward pre‑pandemic target rates as backlog converted to deliveries. [65][69][22] | By 2025–mid‑2026 narrative consolidated into "recovery + execution": backlog provided multi‑year visibility; investors rewarded execution and product roll‑outs (A321XLR). | Sustained multi‑year uptrend since 2022 with periodic news‑led pullbacks; the 2020 drawdown remains the largest historical drawdown in the window — as of 2026‑07‑07 the stock is trading at 203.9. [39][65] |

Key risks and downside factors

Airbus Group spans commercial aircraft, helicopters, defence and space, competing globally against large OEMs, major defence contractors and specialised engine and systems suppliers. Boeing remains the primary commercial rival, though regional manufacturers like Embraer and state-backed competitors such as COMAC exert pressure. Suppliers including Safran, Rolls-Royce and Raytheon Technologies shape both margins and technology trajectories. The business faces structural headwinds: cyclical airline demand and order volatility, the inherent complexity of global supply chains and production execution, currency and financing exposure, and regulatory or geopolitical constraints that can defer deliveries or close markets entirely.

  • Cyclical commercial demand creates structural vulnerability for aircraft manufacturers. When downturns hit, airlines defer or cancel orders, and insolvencies can accelerate. The result flows directly through: fewer deliveries, compressed revenue, and cash that doesn't materialize. The credit risk isn't theoretical—it's baked into the business model, waiting for the cycle to turn.
  • Intense competition from established and emerging OEMs—Boeing, regional players like Embraer, and new entrants such as COMAC—alongside rival engine and systems suppliers including Safran, Rolls-Royce, and RTX creates sustained pressure on pricing and market share.
  • Production and supply-chain execution risk. Supplier shortages, quality issues, or failed production ramp-ups can trigger delivery delays, contractual penalties, and cost overruns on major programmes.
  • Regulatory, geopolitical, and financial exposures—export controls, sanctions, defence procurement volatility, and USD/EUR currency and financing risk—can restrict sales, delay certification, and compress margins.

Competitive landscape

Airbus Group commands leading positions across commercial aircraft, helicopters, and defence/space. It competes directly with Boeing in large commercial airliners and faces formidable competition from U.S. and European defence primes—Lockheed Martin, RTX, Northrop, Thales, Dassault, Textron. The portfolio's diversity (commercial, defence/space, helicopters) exposes the company to cyclical airline demand, structural pricing pressure within the duopoly, and the vulnerabilities embedded in complex multinational supply chains. Production execution and supplier reliability remain persistent pressure points, alongside programme cost discipline and the layered risks of regulatory, geopolitical, and compliance environments [Airbus, Boeing, Lockheed, RTX, Thales, Dassault Wikipedia pages].

Private competitors

  • COMAC (Commercial Aircraft Corporation of China)
  • Aviation Industry Corporation of China (AVIC)
  • United Aircraft Corporation (UAC) / Russian OEM groups (state-controlled, non-listed consolidators)

Get More Stock Analyses Like This

Receive hand-picked stock recommendations with detailed analyses every week

Start Free Trial

Performance Figures of Airbus SE

in EUR

1M High / Low
210.95 / 171.84
52W High / Low
221.25 / 157.48
5Y High / Low
221.25 / 86.53
1M
+15.25%
3M
+21.54%
6M
-3.43%
1Y
+15.90%
3Y
+64.93%
5Y
+97.10%

Relative Performance vs Benchmarks

PeriodAirbus SE vs DAX vs S&P 500 (SPY)
1M +15.25% +13.54% +13.84%
3M +21.54% +16.37% +11.28%
6M -3.43% -2.55% -11.73%
1Y +15.90% +12.47% -5.97%
3Y +64.93% +4.46% -12.05%
5Y +97.10% +37.50% +13.41%

Get More Stock Analyses Like This

Receive hand-picked stock recommendations with detailed analyses every week

Start Free Trial

Historical valuation trends

How the company’s key valuation ratios (P/E, P/S, P/B and P/CF) have evolved over time compared to today.

PeriodP/E RatioP/S RatioP/B RatioP/CF Ratio
Current32.12.26.227.2
1Y ago28.42.06.122.7
3Y ago26.71.76.815.6
5Y ago28.61.69.39.6

Frequently Asked Questions

Where is the Airbus SE stock traded?

The Airbus SE stock trades under the ticker AIR.XETRA on the XETRA exchange. ISIN: NL0000235190.

What does Airbus SE do?

Airbus SE is a company characterized by the following investment thesis:

What are the key metrics for AIR.XETRA?

Key metrics for AIR.XETRA include valuation (P/E 32.7, P/S 2.2, P/B 6.2), profitability (profit margin 6.91%, ROE 19.75%), and growth (revenue —, earnings —). Market capitalization is 162.92B EUR. These metrics give an overview of the company's financial performance and valuation.

How has Airbus SE's stock price performed?

Airbus SE's stock has returned — over 1 year, — over 3 years, and — over 5 years. Performance can vary depending on market conditions and company developments.

How is AIR.XETRA valued?

AIR.XETRA has the following valuation metrics: P/E Ratio: 32.7, P/S Ratio: 2.2, P/B Ratio: 6.2. These metrics help assess whether the stock is fairly valued compared to its fundamentals.

Does AIR.XETRA pay dividends?

Yes, AIR.XETRA pays dividends with a dividend yield of 1.5%. Dividends can be an important component of the total return on an investment.

What are the key risks when investing in AIR.XETRA?

Key risks for AIR.XETRA include: Airbus Group spans commercial aircraft, helicopters, defence and space, competing globally against large OEMs, major defence contractors and specialised engine and systems suppliers. Boeing remains the primary commercial rival, though regional manufacturers like Embraer and state-backed competitors such as COMAC exert pressure. Suppliers including Safran, Rolls-Royce and Raytheon Technologies shape both margins and technology trajectories. The business faces structural headwinds: cyclical airline demand and order volatility, the inherent complexity of global supply chains and production execution, currency and financing exposure, and regulatory or geopolitical constraints that can defer deliveries or close markets entirely.
  • Cyclical commercial demand creates structural vulnerability for aircraft manufacturers. When downturns hit, airlines defer or cancel orders, and insolvencies can accelerate. The result flows directly through: fewer deliveries, compressed revenue, and cash that doesn't materialize. The credit risk isn't theoretical—it's baked into the business model, waiting for the cycle to turn.
  • Intense competition from established and emerging OEMs—Boeing, regional players like Embraer, and new entrants such as COMAC—alongside rival engine and systems suppliers including Safran, Rolls-Royce, and RTX creates sustained pressure on pricing and market share.
  • Production and supply-chain execution risk. Supplier shortages, quality issues, or failed production ramp-ups can trigger delivery delays, contractual penalties, and cost overruns on major programmes.
  • Regulatory, geopolitical, and financial exposures—export controls, sanctions, defence procurement volatility, and USD/EUR currency and financing risk—can restrict sales, delay certification, and compress margins.
Investors should consider these risk factors carefully before making an investment decision.

Who are the main competitors of Airbus SE?

Airbus SE competes with several listed peers in its sector. Airbus Group commands leading positions across commercial aircraft, helicopters, and defence/space. It competes directly with Boeing in large commercial airliners and faces formidable competition from U.S. and European defence primes—Lockheed Martin, RTX, Northrop, Thales, Dassault, Textron. The portfolio's diversity (commercial, defence/space, helicopters) exposes the company to cyclical airline demand, structural pricing pressure within the duopoly, and the vulnerabilities embedded in complex multinational supply chains. Production execution and supplier reliability remain persistent pressure points, alongside programme cost discipline and the layered risks of regulatory, geopolitical, and compliance environments [Airbus, Boeing, Lockheed, RTX, Thales, Dassault Wikipedia pages].
  • The Boeing Company (BA.NYSE)
  • Lockheed Martin Corporation (LMT.NYSE)
  • RTX Corporation (RTX.NYSE)
  • Northrop Grumman Corporation (NOC.NYSE)
  • Textron Inc. (TXT.NYSE)
These competitors influence pricing power, growth opportunities and relative valuation.

When does Airbus SE report earnings?

Airbus SE's next earnings report date is July 29, 2026.

Key Metrics

Market Capitalization
162.92B EUR
P/E Ratio
32.69
Analyst Target Price

Valuation Metrics

P/S Ratio
2.25
P/B Ratio
6.22

Profitability Metrics

Profit Margin
6.91%
Operating Margin
1.48%
Return on Equity
19.75%
Return on Assets
2.48%

Growth Metrics

Revenue Growth
Earnings Growth

Dividend history

Long-term record of paid dividends (amount per share and dividend yield at the time of payment).

YearDividendYield at paymentAvg. yield
20263.20 EUR1.81%1.79%
20253.00 EUR2.20%
20242.80 EUR1.71%
20231.80 EUR1.41%
20221.50 EUR1.42%
20201.80 EUR3.17%
20191.65 EUR1.39%
20181.50 EUR1.64%
20171.35 EUR1.89%
20161.30 EUR2.38%
20151.20 EUR1.93%
20140.75 EUR1.41%
20130.60 EUR1.35%
20120.45 EUR1.72%
20120.39 EUR1.45%

Earnings history & estimates

Historical earnings performance shows how consistently the company meets or exceeds analyst expectations. Forward estimates provide insight into expected profitability and growth trajectory.

Historical earnings performance

35%
Beat estimate
25%
Miss estimate
+26.67%
Avg surprise when beat
-44.97%
Avg surprise when miss

Reports analyzed: 40

Upcoming earnings report

July 29, 2026
Next earnings date

Analyst estimates for upcoming periods

Next year
December 31, 2027
n/a
Next quarter
September 30, 2026
n/a

Key financial figures

All figures in EUR

Selected income statement, balance sheet and cash flow figures. Annual and quarterly, based on reported IFRS/GAAP financials.

20252024202320222021
Revenue73.42B69.23B65.45B58.76B52.15B
Operating income (EBIT)5.24B4.80B4.27B4.74B4.83B
Net income5.22B4.23B3.79B4.25B4.21B
Free cash flow4.42B3.93B3.35B3.82B2.79B
Total assets134.94B129.21B118.87B115.94B107.05B
Equity26.10B19.61B17.70B12.95B9.47B
Net debt2.17B-3.73B-5.15B-4.84B-1.11B
© Leeway
PWP Leeway UG (haftungsbeschränkt)
Leeway Icon